KTTA
Pasithea Therapeutics Corp.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Tiago Reis Marques
IPO Date
2021-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Pasithea Therapeutics Corp.
CEO
Tiago Reis Marques
IPO Date
2021-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 152,783 |
| $0.84 |
| 5 May 2026 | Dumesnil Simon | director | A-Award | Acquired | 152,783 | $0.84 |
| 5 May 2026 | Schneiderman Daniel H | Chief Financial Officer | A-Award | Acquired | 1,129,323 | $0.84 |
| 5 May 2026 | Krishnan Kartik | Chief Medical Officer | A-Award | Acquired | 1,129,323 | $0.84 |
| 5 May 2026 | Leahy Emer | director | A-Award | Acquired | 152,783 | $0.84 |
| 5 May 2026 | Novak Alfred J | director | A-Award | Acquired | 152,783 | $0.84 |
| 5 May 2026 | Krishnan Kartik | officer | Disposed | 0 | $0.00 |
| 17 Apr 2026 | Coastlands Capital LP | 10 percent owner | Disposed | 0 | $0.00 |
| 17 Apr 2026 | Coastlands Capital LP | 10 percent owner | Disposed | 11,233,334 | $0.00 |